↓ Skip to main content

Cochrane Database of Systematic Reviews

Homocysteine-lowering interventions for preventing cardiovascular events

Overview of attention for article published in this source, January 2015
Altmetric Badge

Mentioned by

2 news outlets
1 policy source
15 tweeters
5 Facebook pages
5 Wikipedia pages


109 Dimensions

Readers on

230 Mendeley
Homocysteine-lowering interventions for preventing cardiovascular events
Published by
John Wiley & Sons, Ltd, January 2015
DOI 10.1002/14651858.cd006612.pub4
Pubmed ID

Martí-Carvajal, Arturo J, Solà, Ivan, Lathyris, Dimitrios


Cardiovascular disease, which includes coronary artery disease, stroke and congestive heart failure, is a leading cause of death worldwide. Homocysteine is an amino acid with biological functions in methionine metabolism. A postulated risk factor is an elevated circulating total homocysteine level, which is associated with cardiovascular events. The impact of homocysteine-lowering interventions, given to patients in the form of vitamins B6, B9 or B12 supplements, on cardiovascular events. This is an update of a review previously published in 2009 and 2013.

Twitter Demographics

The data shown below were collected from the profiles of 15 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 230 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 <1%
United Kingdom 1 <1%
Canada 1 <1%
China 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 224 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 44 19%
Researcher 26 11%
Student > Ph. D. Student 26 11%
Student > Bachelor 26 11%
Student > Postgraduate 20 9%
Other 58 25%
Unknown 30 13%
Readers by discipline Count As %
Medicine and Dentistry 99 43%
Nursing and Health Professions 23 10%
Agricultural and Biological Sciences 19 8%
Biochemistry, Genetics and Molecular Biology 9 4%
Pharmacology, Toxicology and Pharmaceutical Science 7 3%
Other 33 14%
Unknown 40 17%